BMRN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Biomarin Pharmaceutical Inc's quarterly cash and cash equivalents increased from Dec. 2013 ($568.8 Mil) to Mar. 2014 ($639.8 Mil) but then declined from Mar. 2014 ($639.8 Mil) to Jun. 2014 ($584.7 Mil).
Biomarin Pharmaceutical Inc's annual cash and cash equivalents increased from Dec. 2011 ($46.3 Mil) to Dec. 2012 ($180.5 Mil) and increased from Dec. 2012 ($180.5 Mil) to Dec. 2013 ($568.8 Mil).
Cash and cash equivalents on banks book.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Biomarin Pharmaceutical Inc Annual Data
Biomarin Pharmaceutical Inc Quarterly Data